KalVista Pharmaceuticals
KALV
KALV
128 hedge funds and large institutions have $557M invested in KalVista Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 33 increasing their positions, 35 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 35
86% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $7.04M
Holders
128
Holding in Top 10
4
Calls
$1.01M
Puts
$7.04M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$22.2M | |
| 3 | +$17.9M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$17.4M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
+$14M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$12.4M | |
| 3 | -$10.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.26M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.78M |